BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20946548)

  • 1. Prevalence of leucocyte antibodies in the Dutch donor population.
    Middelburg RA; Porcelijn L; Lardy N; Briët E; Vrielink H
    Vox Sang; 2011 Apr; 100(3):327-35. PubMed ID: 20946548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.
    Middelburg RA; Beckers EA; Porcelijn L; Lardy N; Wiersum-Osselton JC; Schipperus MR; Vrielink H; Briët E; van der Bom JG
    Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated (immune) transfusion-related acute lung injury.
    Bux J
    Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.
    Middelburg RA; van Stein D; Atsma F; Wiersum-Osselton JC; Porcelijn L; Beckers EA; Briët E; van der Bom JG
    Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
    van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
    Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
    Goodwin J; Tinckam K; denHollander N; Haroon A; Keshavjee S; Cserti-Gazdewich CM
    J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in TRALI.
    Wallis JP
    Transfus Med; 2008 Oct; 18(5):273-5. PubMed ID: 18937732
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
    Nicolle AL; Chapman CE; Carter V; Wallis JP
    Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ; Kauschat D; Bein G
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.